The role of radiation therapy in malignant thymoma: A surveillance, epidemiology, and end results database analysis

Journal of Thoracic Oncology

Volumn 5, Issue 9, 2010, Pages 1454-1460

  Fernandes, Annemarie T ^a   Shinohara, Eric T ^a   Guo, Mengye ^b   Mitra, Nandita ^a   Wilson, Lynn D ^c   Rengan, Ramesh ^a   Metz, James M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac toxicity; Radiation; Secondary malignancy; Thymoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; THYMOMA;

EID: 77956265898     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181e8f345     Document Type: Article

References (29)

1. Engels EA, Pfeiffer RM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 2003;105:546-551.
2. Kondo K, Monden Y. Lymphogenous and hematogenous metastasis of thymic epithelial tumors. Ann Thorac Surg 2003;76:1859-1864; discussion 1864-1865.
3. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003;76:878-884; discussion 884-885.
4. Curran WJ Jr, Kornstein MJ, Brooks JJ, et al. Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 1988;6:1722-1727.
5. Gripp S, Hilgers K, Wurm R, et al. Thymoma: prognostic factors and treatment outcomes. Cancer 1998;83:1495-1503.
6. Urgesi A, Monetti U, Rossi G, et al. Role of radiation therapy in locally advanced thymoma. Radiother Oncol 1990;19:273-280.
7. Mangi AA, Wright CD, Allan JS, et al. Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg 2002;74:1033-1037.
8. Aisenberg AC. Problems in Hodgkin's disease management. Blood 1999;93:761-779.
9. Chaturvedi AK, Engels EA, Gilbert ES, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 2007;99:1634-1643.
10. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993; 270:1949-1955.
11. Paszat LF, Mackillop WJ, Groome PA, et al. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol 1998;16:2625-2631.
12. Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007;168:1-64.
13. Prosnitz RG, Marks LB. Radiation-induced heart disease: vigilance is still required. J Clin Oncol 2005;23:7391-7394.
14. Tubiana M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 2009;91:4-15; discussion 11-13.
15. Yu JB, Gross CP, Wilson LD, et al. NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park) 2009;23:288-295.
16. Lally BE, Zelterman D, Colasanto JM, et al. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 2006;24:2998-3006.
17. Pan CC, Chen PC, Wang LS, et al. Thymoma is associated with an increased risk of second malignancy. Cancer 2001;92:2406-2411.
18. Welsh JS, Wilkins KB, Green R, et al. Association between thymoma and second neoplasms. JAMA 2000;283:1142-1143.
19. Pohjola-Sintonen S, Totterman KJ, Kupari M. Sick sinus syndrome as a complication of mediastinal radiation therapy. Cancer 1990;65:2494-2496.
20. Kleikamp G, Schnepper U, Korfer R. Coronary artery and aortic valve disease as a long-term sequel of mediastinal and thoracic irradiation. Thorac Cardiovasc Surg 1997;45:27-31.
21. Hershman DL, Shao T. Anthracycline cardiotoxicity after breast cancer treatment. Oncology (Williston Park) 2009;23:227-234.
22. Travis LB, Gospodarowicz M, Curtis RE, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 2002;94:182-192.
23. Forquer JA, Rong N, Fakiris AJ, et al. Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional disease. Int J Radiat Oncol Biol Phys 2010;76:440-445.
24. Housman DM, Smith BD, Detterbeck FC, et al. The role of radiation therapy in malignant thymoma: a population-based study. Int J Radiat Oncol Biol Phys 2006;66(Suppl 3):S150.
25. Ruffini E, Mancuso M, Oliaro A, et al. Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardio-vasc Surg 1997;113:55-63.
26. Maggi G, Casadio C, Cavallo A, et al. Thymoma: results of 241 operated cases. Ann Thorac Surg 1991;51:152-156.
27. Arakawa A, Yasunaga T, Saitoh Y, et al. Radiation therapy of invasive thymoma. Int J Radiat Oncol Biol Phys 1990;18:529-534.
28. Ciernik IF, Meier U, Lutolf UM. Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy. J Clin Oncol 1994;12:1484-1490.
29. Urgesi A, Monetti U, Rossi G, et al. Aggressive treatment of intratho-racic recurrences of thymoma. Radiother Oncol 1992;24:221-225.